Angiotensin-converting enzyme 2 (ACE2): SARS-CoV-2 receptor and RAS modulator

The coronavirus disease 2019 (COVID-19) outbreak is caused by severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2). Angiotensin-converting enzyme 2 (ACE2) was rapidly identified as the critical functional receptor for SARS-CoV-2. ACE2 is well-known as a counter-regulator of the renin-angiote...

Full description

Bibliographic Details
Main Authors: Jingwei Bian, Zijian Li
Format: Article
Language:English
Published: Elsevier 2021-01-01
Series:Acta Pharmaceutica Sinica B
Subjects:
Online Access:http://www.sciencedirect.com/science/article/pii/S2211383520307577
_version_ 1819128142434926592
author Jingwei Bian
Zijian Li
author_facet Jingwei Bian
Zijian Li
author_sort Jingwei Bian
collection DOAJ
description The coronavirus disease 2019 (COVID-19) outbreak is caused by severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2). Angiotensin-converting enzyme 2 (ACE2) was rapidly identified as the critical functional receptor for SARS-CoV-2. ACE2 is well-known as a counter-regulator of the renin-angiotensin system (RAS) and plays a key role in the cardiovascular system. Given that ACE2 functions as both a SARS-CoV-2 receptor and a RAS modulator, the treatment for COVID-19 presents a dilemma of how to limit virus entry but protect ACE2 physiological functions. Thus, an in-depth summary of the recent progress of ACE2 research and its relationship to the virus is urgently needed to provide possible solution to the dilemma. Here, we summarize the complexity and interplay between the coronavirus, ACE2 and RAS (including anti-RAS drugs). We propose five novel working modes for functional receptor for SARS-CoV-2 infection and the routes of ACE2-mediated virus entering host cells, as well as its regulatory mechanism. For the controversy of anti-RAS drugs application, we also give theoretical analysis and discussed for drug application. These will contribute to a deeper understanding of the complex mechanisms of underlying the relationship between the virus and ACE2, and provide guidance for virus intervention strategies.
first_indexed 2024-12-22T08:23:07Z
format Article
id doaj.art-7f41d1b6a07e4a468613d7809516ce4e
institution Directory Open Access Journal
issn 2211-3835
language English
last_indexed 2024-12-22T08:23:07Z
publishDate 2021-01-01
publisher Elsevier
record_format Article
series Acta Pharmaceutica Sinica B
spelling doaj.art-7f41d1b6a07e4a468613d7809516ce4e2022-12-21T18:32:42ZengElsevierActa Pharmaceutica Sinica B2211-38352021-01-01111112Angiotensin-converting enzyme 2 (ACE2): SARS-CoV-2 receptor and RAS modulatorJingwei Bian0Zijian Li1Department of Cardiology and Institute of Vascular Medicine, Peking University Third Hospital; Key Laboratory of Cardiovascular Molecular Biology and Regulatory Peptides, Ministry of Health; Key Laboratory of Molecular Cardiovascular Sciences, Ministry of Education; Beijing Key Laboratory of Cardiovascular Receptors Research, Beijing 100191, ChinaDepartment of Cardiology and Institute of Vascular Medicine, Peking University Third Hospital; Key Laboratory of Cardiovascular Molecular Biology and Regulatory Peptides, Ministry of Health; Key Laboratory of Molecular Cardiovascular Sciences, Ministry of Education; Beijing Key Laboratory of Cardiovascular Receptors Research, Beijing 100191, China; Department of Pharmacy, Peking University Third Hospital, Beijing 100191, China; Corresponding author. Tel.: +86 10 82265519.The coronavirus disease 2019 (COVID-19) outbreak is caused by severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2). Angiotensin-converting enzyme 2 (ACE2) was rapidly identified as the critical functional receptor for SARS-CoV-2. ACE2 is well-known as a counter-regulator of the renin-angiotensin system (RAS) and plays a key role in the cardiovascular system. Given that ACE2 functions as both a SARS-CoV-2 receptor and a RAS modulator, the treatment for COVID-19 presents a dilemma of how to limit virus entry but protect ACE2 physiological functions. Thus, an in-depth summary of the recent progress of ACE2 research and its relationship to the virus is urgently needed to provide possible solution to the dilemma. Here, we summarize the complexity and interplay between the coronavirus, ACE2 and RAS (including anti-RAS drugs). We propose five novel working modes for functional receptor for SARS-CoV-2 infection and the routes of ACE2-mediated virus entering host cells, as well as its regulatory mechanism. For the controversy of anti-RAS drugs application, we also give theoretical analysis and discussed for drug application. These will contribute to a deeper understanding of the complex mechanisms of underlying the relationship between the virus and ACE2, and provide guidance for virus intervention strategies.http://www.sciencedirect.com/science/article/pii/S2211383520307577SARS-CoV-2Angiotensin-converting enzyme 2Renin-angiotensin systemReceptorModulatorCOVID-19
spellingShingle Jingwei Bian
Zijian Li
Angiotensin-converting enzyme 2 (ACE2): SARS-CoV-2 receptor and RAS modulator
Acta Pharmaceutica Sinica B
SARS-CoV-2
Angiotensin-converting enzyme 2
Renin-angiotensin system
Receptor
Modulator
COVID-19
title Angiotensin-converting enzyme 2 (ACE2): SARS-CoV-2 receptor and RAS modulator
title_full Angiotensin-converting enzyme 2 (ACE2): SARS-CoV-2 receptor and RAS modulator
title_fullStr Angiotensin-converting enzyme 2 (ACE2): SARS-CoV-2 receptor and RAS modulator
title_full_unstemmed Angiotensin-converting enzyme 2 (ACE2): SARS-CoV-2 receptor and RAS modulator
title_short Angiotensin-converting enzyme 2 (ACE2): SARS-CoV-2 receptor and RAS modulator
title_sort angiotensin converting enzyme 2 ace2 sars cov 2 receptor and ras modulator
topic SARS-CoV-2
Angiotensin-converting enzyme 2
Renin-angiotensin system
Receptor
Modulator
COVID-19
url http://www.sciencedirect.com/science/article/pii/S2211383520307577
work_keys_str_mv AT jingweibian angiotensinconvertingenzyme2ace2sarscov2receptorandrasmodulator
AT zijianli angiotensinconvertingenzyme2ace2sarscov2receptorandrasmodulator